203 related articles for article (PubMed ID: 32885364)
1. Advanced glycation end products (AGEs) synergistically potentiated the proinflammatory action of lipopolysaccharide (LPS) and high mobility group box-1 (HMGB1) through their direct interactions.
Watanabe M; Toyomura T; Tomiyama M; Wake H; Liu K; Teshigawara K; Takahashi H; Nishibori M; Mori S
Mol Biol Rep; 2020 Sep; 47(9):7153-7159. PubMed ID: 32885364
[TBL] [Abstract][Full Text] [Related]
2. Cationic ribosomal proteins can inhibit pro-inflammatory action stimulated by LPS+HMGB1 and are hindered by advanced glycation end products.
Watanabe M; Toyomura T; Wake H; Nishinaka T; Hatipoglu OF; Takahashi H; Nishibori M; Mori S
Biotechnol Appl Biochem; 2024 Apr; 71(2):264-271. PubMed ID: 38010900
[TBL] [Abstract][Full Text] [Related]
3. Identification of ribosomal protein L9 as a novel regulator of proinflammatory damage-associated molecular pattern molecules.
Watanabe M; Toyomura T; Wake H; Nishinaka T; Hatipoglu OF; Takahashi H; Nishibori M; Mori S
Mol Biol Rep; 2022 Apr; 49(4):2831-2838. PubMed ID: 35059969
[TBL] [Abstract][Full Text] [Related]
4. [Regulation of inflammatory response based on interaction among AGEs, DAMPs, and/or cytokines].
Watanabe M; Toyomura T; Mori S
Nihon Yakurigaku Zasshi; 2022; 157(6):429-433. PubMed ID: 36328554
[TBL] [Abstract][Full Text] [Related]
5. HMGB1 enhances the proinflammatory activity of lipopolysaccharide by promoting the phosphorylation of MAPK p38 through receptor for advanced glycation end products.
Qin YH; Dai SM; Tang GS; Zhang J; Ren D; Wang ZW; Shen Q
J Immunol; 2009 Nov; 183(10):6244-50. PubMed ID: 19890065
[TBL] [Abstract][Full Text] [Related]
6. [Towards Understanding the Pathophysiological Significance of Cytokine Trapping Mediated by Advanced Glycation End Products].
Watanabe M
Yakugaku Zasshi; 2020; 140(11):1335-1341. PubMed ID: 33132269
[TBL] [Abstract][Full Text] [Related]
7. Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein.
Park JS; Svetkauskaite D; He Q; Kim JY; Strassheim D; Ishizaka A; Abraham E
J Biol Chem; 2004 Feb; 279(9):7370-7. PubMed ID: 14660645
[TBL] [Abstract][Full Text] [Related]
8. Trimebutine attenuates high mobility group box 1-receptor for advanced glycation end-products inflammatory signaling pathways.
Nakajima S; Ogawa N; Yokoue N; Tachibana H; Tamada K; Okazawa M; Sato A; Oyama T; Abe H; Kamiya T; Yoshimori A; Yoshizawa K; Inoue S; Yokomizo T; Uchiumi F; Abe T; Tanuma SI
Biochem Biophys Res Commun; 2020 Dec; 533(4):1155-1161. PubMed ID: 33041002
[TBL] [Abstract][Full Text] [Related]
9. Dietary advanced glycation end-products, its pulmonary receptor, and high mobility group box 1 in aspiration lung injury.
Smit PJ; Guo WA; Davidson BA; Mullan BA; Helinski JD; Knight PR
J Surg Res; 2014 Sep; 191(1):214-23. PubMed ID: 24814199
[TBL] [Abstract][Full Text] [Related]
10. DNA-Aptamer Raised against Receptor for Advanced Glycation End Products Improves Survival Rate in Septic Mice.
Koga Y; Sotokawauchi A; Higashimoto Y; Nishino Y; Hashizume N; Kakuma T; Akiba J; Tanaka Y; Matsui T; Yagi M; Yamagishi SI
Oxid Med Cell Longev; 2021; 2021():9932311. PubMed ID: 34413930
[TBL] [Abstract][Full Text] [Related]
11. Inhibition effect of glycyrrhizin in lipopolysaccharide-induced high-mobility group box 1 releasing and expression from RAW264.7 cells.
Wu CX; He LX; Guo H; Tian XX; Liu Q; Sun H
Shock; 2015 Apr; 43(4):412-21. PubMed ID: 25526376
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of HMGB1/RAGE-mediated endocytosis by HMGB1 antagonist box A, anti-HMGB1 antibodies, and cholinergic agonists suppresses inflammation.
Yang H; Liu H; Zeng Q; Imperato GH; Addorisio ME; Li J; He M; Cheng KF; Al-Abed Y; Harris HE; Chavan SS; Andersson U; Tracey KJ
Mol Med; 2019 Apr; 25(1):13. PubMed ID: 30975096
[TBL] [Abstract][Full Text] [Related]
13. High-mobility group box 1 inhibits HCO(3)(-) absorption in medullary thick ascending limb through a basolateral receptor for advanced glycation end products pathway.
Good DW; George T; Watts BA
Am J Physiol Renal Physiol; 2015 Oct; 309(8):F720-30. PubMed ID: 26180239
[TBL] [Abstract][Full Text] [Related]
14. Papaverine identified as an inhibitor of high mobility group box 1/receptor for advanced glycation end-products interaction suppresses high mobility group box 1-mediated inflammatory responses.
Tamada K; Nakajima S; Ogawa N; Inada M; Shibasaki H; Sato A; Takasawa R; Yoshimori A; Suzuki Y; Watanabe N; Oyama T; Abe H; Inoue S; Abe T; Yokomizo T; Tanuma S
Biochem Biophys Res Commun; 2019 Apr; 511(3):665-670. PubMed ID: 30826057
[TBL] [Abstract][Full Text] [Related]
15. High mobility group box 1 protein binding to lipopolysaccharide facilitates transfer of lipopolysaccharide to CD14 and enhances lipopolysaccharide-mediated TNF-alpha production in human monocytes.
Youn JH; Oh YJ; Kim ES; Choi JE; Shin JS
J Immunol; 2008 Apr; 180(7):5067-74. PubMed ID: 18354232
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of HMGB1 A-box reduced lipopolysaccharide-induced intestinal inflammation via HMGB1/TLR4 signaling in vitro.
Wang FC; Pei JX; Zhu J; Zhou NJ; Liu DS; Xiong HF; Liu XQ; Lin DJ; Xie Y
World J Gastroenterol; 2015 Jul; 21(25):7764-76. PubMed ID: 26167076
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of the receptor for advanced glycation inhibits lipopolysaccharide-mediated High mobility group protein B1 and Interleukin-6 synthesis in human gingival fibroblasts through the NF-κB signaling pathway.
Huang J; Xiong T; Zhang Z; Tan Y; Guo L
Arch Oral Biol; 2019 Sep; 105():81-87. PubMed ID: 31288145
[TBL] [Abstract][Full Text] [Related]
18. Indoprofen exerts a potent therapeutic effect against sepsis by alleviating high mobility group box 1-mediated inflammatory responses.
Bi X; Yan X; Jiang B; Liang J; Zhou J; Lu S; Liu J; Luo L; Yin Z
Toxicol Appl Pharmacol; 2021 Dec; 433():115778. PubMed ID: 34755645
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effects of lycopene on HMGB1-mediated pro-inflammatory responses in both cellular and animal models.
Lee W; Ku SK; Bae JW; Bae JS
Food Chem Toxicol; 2012 Jun; 50(6):1826-33. PubMed ID: 22429818
[TBL] [Abstract][Full Text] [Related]
20. Polyphosphate amplifies proinflammatory responses of nuclear proteins through interaction with receptor for advanced glycation end products and P2Y1 purinergic receptor.
Dinarvand P; Hassanian SM; Qureshi SH; Manithody C; Eissenberg JC; Yang L; Rezaie AR
Blood; 2014 Feb; 123(6):935-45. PubMed ID: 24255918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
